drugset / Trial / NCT00198536

Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

NCT00198536

Phase 2/3 Completed 159 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether ecabet ophthalmic solution is an effective treatment for dry eye syndrome

Timeline

Start
2005-04
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecabet Small molecule 2.83 % Other
Subject Ecabet Small molecule 3.7 % Other

Indications